跳至主要内容
临床试验/EUCTR2006-002550-30-AT
EUCTR2006-002550-30-AT进行中(未招募)不适用

A randomized controlled pilot study for the comparison of efficacy of bronchoalveolar lavage (BAL) with Curosurf® in a dosage 50 mg/kg vs not treated control in adult patients affected by pulmonary contusion from chest trauma at risk of ALI/ARDS using low tidal volume ventilation treatment. Suggested Acronym:BALCAPULCO (BAL with Curosurf® in Adults with PULmonary COntusion) - BALCAPULCO

Chiesi Farmaceutici S. p. A.0 个研究点目标入组 120 人开始时间: 2006年10月9日最近更新:

试验速览

阶段
不适用
状态
进行中(未招募)
发起方
入组人数
120

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional clinical trial of medicinal product

入排标准

性别
All

入选标准

  • -The subject must be between 18 - 70 years of age
  • -The subjects must have a diagnosis based on clinical signs and /or radiographic and CT scan evidence of uni- or bilateral lung contusion involving one or more lobes
  • -Subject must be intubated and artificially ventilated
  • -Subject must be at ICU and randomised to one of the study arms within = 6 hours of trauma
  • -Subject must be in a clinically stable condition with efficacious, stable ventilation support for one hour before BAL, which therefore must be performed after a maximum of 7 hours from trauma.
  • -Evidence for date and time of the trauma must be available; the maximum admissible time uncertainty must not exceed 30 minutes.
  • Are the trial subjects under 18? no
  • Number of subjects for this age range:
  • F.1.2 Adults (18-64 years) yes
  • F.1.2.1 Number of subjects for this age range
  • F.1.3 Elderly (>=65 years) yes
  • F.1.3.1 Number of subjects for this age range

排除标准

  • -Subjects with an anamnestically known hypersensitivity against surfactants
  • -Subject is female with childbearing potential and a (in such cases mandatory) pregnancy test is positive
  • -Subjects who have at least one other source of severe lung injury due to inhalation of toxic gases, burnings, acids or similar substances in addition to the lung contusion
  • -Subjects who suffer from anamnestically known chronic lung disease (COPD) Stage III
  • -Subjects who suffer from anamnestically known status asthmaticus
  • -Subject with severe ventilation refractory hypoxemia: paO2/FiO2 < 50 with PEEP > 12 mbar during stabilisation on ICU
  • -Subjects with congestive heart failure and/or uncorrected congenital heart disease
  • -Subjects with cardiogenic pulmonary edema
  • -Subjects who have their hemo- and/or pneumothorax not adequately resolved several minutes prior randomisation.
  • -Subjects who need abdominal and/or lung surgery
  • -Subjects with severe brain injury (Glasgow Coma Scale < 10), need for neurosurgery, brain death
  • -Terminal patients with an estimated life expectancy of less than 4 weeks
  • -Subjects who are treated with another surfactant during the whole study period
  • -Subject´s demand for another experimental drug
  • -Subject´s demand for medications which could be dangerous for the patient according to their SPC
  • -Subject´s demand for non depolarizing muscle relaxants (except during bronchoscopy)
  • -Subjects with presence of abdominal lesions which are known to create severe post-operative complications (e.g. sepsis, delay in intestinal canalization, etc.)
  • -Subjects with a Body Mass Index BMI > 30.
  • -Subject is anamnestically known for participation in other clinical studies or termination of other clinical trials within two months prior trauma.
  • -Subjects with available evidence of legal restrictions for their ability to provide informed consent (e.g., soldiers, prisoners, severe mental diseases, severe drug addiction etc.)

研究者

发起方
Chiesi Farmaceutici S. p. A.

相似试验

进行中(未招募)
不适用
A randomized controlled pilot study for the comparison of efficacy of bronchoalveolar lavage BAL with Curosurf in a dosage 50 mg/kg vs not treated control in adult patients affected by pulmonary contusion from chest trauma at risk of ALI/ARDS using low tidal volume ventilation treatment. - Balcapulcoadult patients affected by pulmonary contusion from chest trauma at risk of ALI/ARDSMedDRA version: 9.1Level: LLTClassification code 10061230Term: Lung injury
EUCTR2006-002550-30-ITCHIESI100
撤回
不适用
The comparison of the disposable Negative Pressure Wound Therapy Device (NPWT) to current standard dressings on medium sized Split Skin Grafts (SSG)Split Skin GraftSurgery - Surgical techniquesSkin - Other skin conditions
ACTRN12612000702819Dr Anthony Farfus30
尚未招募
3 期
Treatment of Hypertriglyceridemia with Fucus Vesiculosus vs Atorvastati
CTRI/2023/07/055898Central Council for Research in Homoeopathy
已完成
不适用
A randomised, controlled pilot study to compare the effect of preoperative binaural beat audio with patient-selected music on subsequent anaesthetic drug requirementsSurgery: AnaesthesiaSurgeryAnaesthesia
ISRCTN55755275Record Provided by the NHSTCT Register - 2006 Update - Department of Health20
招募中
2 期
To assess by a randomised,pilot study which of the two treatment regimens i.e. Rituximab infusion or Dexamethasone pulse therapy is more efficacious in the treatment of pemphigus vulgaris and relationship of various immunological parameters in skin and blood
CTRI/2018/12/016531DR SUJAY KHANDPUR